Literature DB >> 22146765

Postoperative chylous ascites in patients with gynecologic malignancies.

Duo Han1, Xiaohua Wu, Jin Li, Guihao Ke.   

Abstract

OBJECTIVE: To evaluate the incidence and the effective treatment of postoperative chylous ascites in patients with gynecologic malignancies.
METHODS: In this report, we retrospectively reviewed the cases of 4119 patients who underwent pelvic and/or para-aortic lymph node dissection for gynecologic malignancies in Fudan University Cancer Hospital.
RESULTS: Among these 4119 cases, 7 (0.17%) patients had chylous ascites postoperatively. The average age of these patients was 52 years. The mean time interval between operation and the appearance of chylous ascites was 30 days (range, 5-75 days). The incidence of chylous ascites after para-aortic lymphadenectomy was approximately 0.32% (5/1540), whereas the rate after pelvic lymphadenectomy alone was 0.077% (2/2579). All cases with chylous ascites were resolved by conservative treatment. This included placement of a peritoneal drainage tube. The mean time to resolution was 13 days (range, 2-28 days). None of the cases had recurrent chylous ascites during follow-up.
CONCLUSIONS: Para-aortic lymph node dissection may be associated with postoperative chylous ascites. Patients may have their chylous ascites successfully treated with conservative management. An abdominal drainage tube can be a simple and effective approach and should be considered in the treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22146765     DOI: 10.1097/IGC.0b013e318233f24b

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  8 in total

1.  A case of left renal atrophy following the development of an infected giant retroperitoneal chylous cyst after laparoscopic para-aortic lymphadenectomy for endometrial cancer.

Authors:  Takuma Ohsuga; Yasushi Kotani; Shiro Takamatsu; Keisuke Murakami; Hidekatsu Nakai; Noriomi Matsumura
Journal:  Int Cancer Conf J       Date:  2020-06-09

2.  Management of postoperative chylous ascites after surgery for ovarian cancer: a single-institution experience.

Authors:  Giuseppe Scaletta; Lorena Quagliozzi; Stefano Cianci; Virginia Vargiu; Maria Cristina Mele; Giovanni Scambia; Anna Fagotti
Journal:  Updates Surg       Date:  2019-04-20

3.  Risk factors of chylous ascites and its relationship with long-term prognosis in laparoscopic D3 lymphadenectomy for right colon cancer.

Authors:  Wei Qin; Dechang Diao; Kai Ye; Ximo Xu; Duohuo Shu; Hao Zhong; Yanyan Hu; Xiao Yang; Batuer Aikemu; Leqi Zhou; Sen Zhang; Pei Xue; Zhenghao Cai; Minhua Zheng; Jianwen Li; Quan Wang; Yueming Sun; Bo Feng
Journal:  Langenbecks Arch Surg       Date:  2022-05-20       Impact factor: 2.895

4.  Recurrent lymphatic ascites in a patient cured of cervical carcinoma.

Authors:  John P Micha; Alberto A Mendivil; John S Cupp; Bram H Goldstein
Journal:  Gynecol Oncol Case Rep       Date:  2012-05-16

5.  Risk factor analysis for massive lymphatic ascites after laparoscopic retroperitonal lymphadenectomy in gynecologic cancers and treatment using intranodal lymphangiography with glue embolization.

Authors:  Tae Wook Kong; Suk Joon Chang; Jinoo Kim; Jiheum Paek; Su Hyun Kim; Je Hwan Won; Hee Sug Ryu
Journal:  J Gynecol Oncol       Date:  2016-07       Impact factor: 4.401

6.  Lymphatic leakage after pelvic lymphadenectomy for cervical cancer: a retrospective case-control study.

Authors:  Li Chen; Liang Lin; Ling Li; Zuolian Xie; Haixin He; Cuibo Lin; Jian Chen; An Lin
Journal:  BMC Cancer       Date:  2021-11-18       Impact factor: 4.430

7.  Nomogram for predicting chylous ascites after right colectomy.

Authors:  Hui-Da Zheng; Yu-Rong Liu; Zhen-Ze Chen; Ya-Feng Sun; Chun-Hao Xu; Jian-Hua Xu
Journal:  World J Gastrointest Surg       Date:  2021-11-27

8.  Independent Risk Factors of Postoperative Lymphatic Leakage in Patients with Gynecological Malignant Tumor: A Single-Center Retrospective Study.

Authors:  Min Du; Lei Wang; Liyun Zhao; Wei Huang; Xiaoling Fang; Xiaomeng Xia
Journal:  Med Sci Monit       Date:  2021-07-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.